Efficacy of melatonin in decreasing the incidence of delirium in critically ill adults: a randomized controlled trial
Open Access
- 1 January 2024
- journal article
- research article
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 36
Abstract
Objective: To determine whether enteral melatonin decreases the incidence of delirium in critically ill adults. Methods: In this randomized controlled trial, adults were admitted to the intensive care unit and received either usual standard care alone (Control Group) or in combination with 3mg of enteral melatonin once a day at 9 PM (Melatonin Group). Concealment of allocation was done by serially numbered opaque sealed envelopes. The intensivist assessing delirium and the investigator performing the data analysis were blinded to the group allocation. The primary outcome was the incidence of delirium within 24 hours of the intensive care unit stay. The secondary outcomes were the incidence of delirium on Days 3 and 7, intensive care unit mortality, length of intensive care unit stay, duration of mechanical ventilation and Glasgow outcome score (at discharge). Results: We included 108 patients in the final analysis, with 54 patients in each group. At 24 hours of intensive care unit stay, there was no difference in the incidence of delirium between Melatonin and Control Groups (29.6 versus 46.2%; RR = 0.6; 95%CI 0.38 - 1.05; p = 0.11). No secondary outcome showed a statistically significant difference. Conclusion: Enteral melatonin 3mg is not more effective at decreasing the incidence of delirium than standard care is in critically ill adults.Keywords
This publication has 26 references indexed in Scilit:
- Prophylactic melatonin for delirium in critically ill patients: A systematic review and meta-analysis with trial sequential analysisMedicine, 2022
- Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trialIntensive Care Medicine, 2022
- The Effects of Melatonin Supplementation on Sleep Quality and Assessment of the Serum Melatonin in ICU Patients: A Randomized Controlled TrialCritical Care Medicine, 2020
- Ramelteon for Prevention of Postoperative Delirium: A Randomized Controlled Trial in Patients Undergoing Elective Pulmonary Thromboendarterectomy*Critical Care Medicine, 2019
- Effectiveness of Melatonin for the Prevention of Intensive Care Unit DeliriumPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2019
- Prevalence, Risk Factors, and Outcomes of Delirium in Mechanically Ventilated Adults*Critical Care Medicine, 2015
- Cognitive Functioning, Mental Health, and Quality of Life in ICU Survivors: An OverviewAnesthesiology Clinics, 2011
- Incidence, risk factors and consequences of ICU deliriumIntensive Care Medicine, 2006
- Abolished circadian rhythm of melatonin secretion in sedated and artificially ventilated intensive care patientsActa Anaesthesiologica Scandinavica, 2004
- Evaluation of delirium in critically ill patients: Validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)Critical Care Medicine, 2001